Correction: FcγRIIA signalling as a host-associated determinant of endosomal trafficking and antibody-dependent enhancement in flavivirus infection - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: The Role of FcγRIIA Signaling in Endosomal Trafficking and Antibody-Dependent Enhancement During Flavivirus Infections

  • By

  • Nensar Wai Wai Phyo Rakwi

  • Daisuke Muraoka

  • Kazumi Haga

  • Adeline Syin Lian Yeo

  • Meng Ling Moi

  • August 21, 2026

Share

Clinical Scorecard: Correction: The Role of FcγRIIA Signaling in Endosomal Trafficking and Antibody-Dependent Enhancement During Flavivirus Infections

At a Glance

CategoryDetail
ConditionFlavivirus Infections
Key MechanismsFcγRIIA signaling and endosomal trafficking
Target PopulationIndividuals infected with flavivirus
Care SettingResearch and clinical immunology

Key Highlights

  • Correction of ethics statement regarding Institutional Review Board approval
  • Clarification on informed consent requirements under national legislation
  • No animal experiments were conducted in the study
  • Human specimens were collected under ethical approvals

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified

          Not specified

          Clinical Best Practices

          • Ensure compliance with local legislation and institutional requirements for ethical approvals
          • Obtain necessary approvals for human-derived samples

          Related Resources & Content

          Original Source(s)

          Correction: FcγRIIA signalling as a host-associated determinant of endosomal trafficking and antibody-dependent enhancement in flavivirus infection

          • by Nensar Wai Wai Phyo Rakwi, Daisuke Muraoka, Kazumi Haga, Adeline Syin Lian Yeo, Meng Ling Moi

          • August 21, 2026

          Related Content

          Adjunctive inhaled antibiotics should not necessarily be considered independently of the systemic antibiotic regimen

          Correction: The gut-liver-immune axis: structural basis, cellular architecture, molecular mediators, and disease-specific manifestations

          Immunization Awareness Month: How RTs Help Protect Patients